Cognigenics announced it raised $1.59 Million in an initial filing from an offering of $1.59 Million

Company

Location

About

Cognigenics is leveraging the power of gene therapies to enhance human cognitive performance. Our technology is broadly applicable to a wide spectrum of cognitive issues which affect 80 million Americans including stress, anxiety and depression.